Cochrane · systematic review · CD004311
Opioids for the management of breakthrough pain in cancer patients
Zeppetella Giovambattista, Davies Andrew N · Cochrane Database of Systematic Reviews · 2013 · Cochrane Library
Pain, Palliative and Supportive CareAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
1
current version
GRADE rated
1
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 1 · 100%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Transmucosal fentanyl compared with placebo for breakthrough pain in cancer patients
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
PID change at 15 min Transmucosal fentanyl vs placebo | no estimate extracted | 7 studies · 1076 participants | High |